Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
dLocal Limited Announces Dismissal of New York State Securities Class Action
-
AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease
-
Safe Pro Reports on Share Repurchase Program, Reinforcing Commitment to Shareholder Value and Capital Return
-
Aventis Energy Intersects Anomalous Radioactivity in Multiple Drill Holes at the Corvo Uranium Project and Concludes Inaugural Drill Program
-
Take 5 Oil Change Expands Footprint in Daytona Beach with New Location
-
Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks
-
Fiserv to Release First Quarter Earnings Results on May 5, 2026 and Confirms Details for May 14, 2026 Investor Day
-
Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates
-
LifeVantage Inspires with ‘Breakthrough’ Announcements at 2026 Momentum Academy in Las Vegas
-
Kornit Digital Expands Digital Production into Footwear and Technical Textiles with Presto MAX PLUS
-
Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026
-
Enlight to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026
-
Genius Group Receives ICC Arbitration Award, Wins Return of 7.4 Million Shares and $8.0 Million Cash Payment
-
2027 Kia Telluride Adds Hybrid Option Rated at Up to 35 MPG
-
MainStreet Bancshares, Inc. Announces First Quarter 2026 Results
-
Standard Dental Labs Inc. Appoints Brendan Cummins to Board of Directors
-
CareCloud to Announce First Quarter 2026 Results on May 7, 2026
-
Maxus Mining Continues to Return Strong Polymetallic Results at the Quarry Antimony Property in British Columbia, Canada
-
The Double D Foundation Announces Major Gift From Patriot Mobile
-
M2i Global, along with Volato Group, and Regenerate Technology Global Execute Strategic Partnership to Advance Battery Recycling Technologies to the U.S.
-
Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026
-
Cole West Closes on 38 Homesites in Northern Utah for New Community
-
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
-
Royale® Launches “There for All”: A New Platform Celebrating the Moments That Matter Most to Canadians
-
Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026
-
COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations
-
Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter
-
VVC Grants Options
-
ASML reports transactions under its current share buyback program
-
Mountain Warehouse Launches Composable Ecommerce Store with BigCommerce to Accelerate Innovation and Global Growth
-
Max Immunity Clinic Opens in Markham, Offering Regenerative and Recovery-Based Therapies
-
American Hotel Income Properties REIT LP Announces Settlement with Its Hotel Management Company
-
Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer
-
Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET
-
Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve
-
Group Coaching Weekly Launches Live Program Focused on Structured Thinking and Real-Time Growth
-
BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure
-
LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdo
-
Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure
-
Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq
-
AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease
-
Airsys Introduces Next-Generation LiquidRack™ Technology to Provide a Simpler Liquid Cooling Architecture for Retrofit, Edge, and Mid-Density AI Infrastructure
-
Astec Names Chad Hartley Group President – Infrastructure Solutions
-
Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
-
Abacus Global Management to Participate in the 2026 Milken Institute Global Conference
-
Global Uranium Completes Phase 1 Earn-In at Astro Project and Secures Initial 20% Interest
-
ZJK Industrial Co., Ltd. Advances Localization Strategy in Vietnam to Strengthen Global Production Network
-
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
-
Aptean introduces AI platform and AI agents for Business Central On-Premises Customers
-
Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor

